Based on preclinical data, we designed a phase I/II clinical trial to determine the efficacy and toxicity of doxorubicin followed by paclitaxel in the treatment of advanced breast cancer (either untreated or relapsed after
Alberto Ravaioli, MD
Advertisement
Articles by Alberto Ravaioli, MD
Advertisement
Latest Updated Articles
- Doxorubicin and Paclitaxel (Sequential Combination) in the Treatment
Published: April 1st 1997 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Supportive Care Methods Can Improve Oncology Outcomes
2
Pembrolizumab Regimen May Show Synergy in Melanoma Populations
3
Chlorotoxin-Based Therapy Shows Safety, Feasibility in Glioblastoma
4
Ezabenlimab Combo Yields Activity in Advanced Squamous Cell Anal Carcinoma
5
